Can China Ace The CAR-T Race?

 
• By Brian Yang

Helped by Nanjing Legend's multimillion dollar deal with J&J, China has now overtaken the US in number of clinical trials using CAR-T cell approaches to treating cancers, but could uncertainties derail the country's CAR-T train from steaming ahead?

Destruction of leukaemia cell, conceptual image. 3D illustration which can be used to illustrate blood cancer treatment
CHINA OVERTAKES THE US IN CAR-T TRIALS

More from China

More from Focus On Asia